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Established facts 1 
・ Neonatal leukemia has poor prognosis. 2 
・ Neonatal leukemia associated with Down syndrome has a natural tendency to 3 
undergo spontaneous remissions and reported mortality rate is much lower than that 4 
without Down syndrome. 5 
・ Significant number of neonatal leukemia arises in utero and fetal leukemia should 6 
be kept in mind as an important cause of intrauterine deterioration and death. 7 
・ Hepatosplenomegaly and hydrops fetalis are two characteristic prenatal features of 8 
congenital leukemia. 9 
 10 
Novel Insights 11 
・ Prenatal course of leukemic fetus including sequential changes in the 12 
ultrasonographic findings, pulse Doppler indices, and fetal heart rate patterns is 13 
specified for the first time. 14 
・ Experience in our case suggests elevation of pulsatility index of the umbilical artery 15 
with paradoxically enlarged fetal trunk as an early sign of fetal leukemia. 16 
・ Experiences in our case and in the past reported cases suggest two distinct 17 
mechanisms for hydrops development caused by fetal leukemia.  The first is 18 
leukemic cell involvement of multiple fetal organs including placenta and the second 19 
is chronic circulatory insufficiency due to hyperviscosity attributable to leukocytosis. 20 
・ Prenatal diagnoses of fetal leukemia have been reported in only 10 cases, all of 21 
which were associated with trisomy 21.  This suggests that leukemic fetuses 22 
associated with Down syndrome are likely to have a milder prenatal course than those 23 
without Down syndrome, thus giving a time for cordocentesis. 24 
25 
 2 




  We here describe a case of congenital leukemia that ended in intrauterine fetal demise 5 
at 30 weeks of gestation.  Acute enlargement of the fetal trunk, elevated pulsatility 6 
index of the umbilical artery with concomitant decline of pulsatility index of middle 7 
cerebral artery, pleural effusion, and polyhydramnios preceded the fetal death.  8 
Diagnosis of congenital myeloid leukemia was suggested by microscopic examination 9 
of the placental tissue, revealing immature myeloid precursors filling the lumina of fetal 10 
vessels in the umbilical cord and chorionic villi.  Extensive vascular involvement of 11 
the placenta by leukemic cells was considered to be a primary cause of the fetal death. 12 
 13 
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  Neonatal leukemia, which occurs at a rate of 1 per 5 million births, is the leading 3 
cause of neonatal death due to neoplastic disease [1].  Recent molecular studies 4 
indicate that significant number of neonatal leukemia arises in utero [2].  In this 5 
respect, fetal leukemia should be kept in mind as an important cause of intrauterine 6 
deterioration and death.  However, prenatal history of congenital leukemia has not 7 
been well characterized.  Herein, we describe a case of congenital leukemia where 8 
acute enlargement of the fetal trunk, elevated pulsatility index of the umbilical artery 9 
with concomitant decline of pulsatility index of the middle cerebral artery, pleural 10 




Case Report 1 
 2 
  A 35-year-old woman (gravida 0, prara 0) at 27+5 weeks’ gestation was referred and 3 
admitted to our hospital due to moderate amount of vaginal bleeding from total placenta 4 
previa.  She was taking antipsychotic medication for schizophrenic disorder. Her 5 
blood screening was negative for irregular antibody or treponema pallidum.  Recent 6 
infection with rubella was also excluded. 7 
  After hospitalization, bleeding gradually decreased and disappeared with bed rest and 8 
tocolytic administration.  On admission, fetal measurements of biparietal diameter 9 
(BPD), fetal trunk area (FTA), and femur length (FL) were all within the normal range.  10 
No fetal malformation was noted and amniotic fluid volume was normal.  Pulsatility 11 
indices of umbilical artery (UmA-PI) and middle cerebral artery (MCA-PI) measured 12 
with Doppler ultrasonography (Voluson730Pro; GE Healthcare, Austria) were all within 13 
the normal level (Figure 1A and B).  Fetal heart rate (FHR) monitoring showed 14 
reassuring pattern. 15 
  At 29+6 weeks’ gestation, UmA-PI was elevated beyond the normal limit (Figure 1A).  16 
MCA-PI was decreased but remained within the normal range (Figure 1B).  Although 17 
BPD and FL was within the normal limits, FTA was abruptly enlarged to 64.29 cm2 18 
(+2.3SD).  FHR monitoring showed reassuring pattern. 19 
  At 30+2 weeks’ gestation, the patient felt diminished fetal movement.  20 
Ultrasonography showed polyhydramnios (Figure 1C) and mild fetal pleural effusion 21 
(Figure 1D).  Further elevation of UmA-PI and decline of MCA-PI was noted (Figure 22 
1A and B).  Doppler waveform of bilateral uterine artery was normal.  FTA was 23 
increased to 68.23 cm2 (+2.6SD).  FHR monitoring exhibited decreased beat-to-beat 24 
variability (Figure 2A). 25 
  At 30+3 weeks’ gestation, FHR monitoring showed small dip-like deceleration 26 
observed on every uterine contraction, which disappeared after tocolysis (Figure 2B).  27 
UmA-PI was further elevated and MCA-PI fell below the normal limit (Figure 1A and 28 
B).  Doppler waveforms of the inferior vena cava and ductus venosus were normal.  29 
Anticipating the need of expeditious premature delivery, maternal betamethasone was 30 
administered for the prevention of neonatal respiratory distress syndrome.  Three hours 31 
later, mild bradycardia (100-110 beat per minute) with loss of variability was noted and 32 
fetal heartbeat suddenly became undetectable (Figure 2C).  Ultrasonography 33 
 5 
confirmed the fetal death. 1 
  Two days later, a male stillborn weighing 1872 g (+1.3SD) was delivered with 2 
cesarean section indicated for total placenta previa.  The newborn was macerated, but 3 
no apparent external malformation was noted.  The parents declined to have the 4 
autopsy.  Postpartum studies on the maternal serum excluded recent infection with 5 
cytomegalovirus, parvovirus, herpes simplex, or toxoplasma. 6 
  Grossly, the placenta (410 g in weight) appeared normal.  Umbilical cord (24 cm in 7 
length) was inserted into the central portion of the placental disc without any sign of 8 
stricture or overcoiling.  The fetal surface of the placenta was translucent.  9 
Microscopically, numerous small- to medium-sized atypical immature-looking cells 10 
with high nuclear to cytoplasmic ratio were observed in the fetal vessels including 11 
intravillous capillaries as well as medium- to large-sized veins and arteries in the 12 
chorionic plate and the umbilical cord (Figure 3A, B and C).  On the other hand, 13 
maternal vessels in the decidual tissue and intervillous spaces were free of 14 
above-mentioned atypical cells.  In some areas, intervillous fibrin deposition and 15 
thrombosis was identified.  Immunohistochemically, these atypical cells were positive 16 
for myeloperoxidase (Figure 3D) and negative for CD3 (T-cell marker) and CD20 17 
(B-cell marker), indicating the myeloid lineage of differentiation.  The Ki-67 (MIB-1) 18 
labeling index was up to 50% (Figure 3E).  This constellation of findings suggested 19 





  In the current case, cause of the sudden fetal deterioration and death had been totally 3 
unknown until the placental pathology was reported.  Possible causes for fetal pleural 4 
effusion associated with polyhydramnios such as cardiopulmonary anomaly, congenital 5 
infection, and erythroblastosis fetalis were excluded by the fetal ultrasonography and 6 
maternal blood tests.  Numerous atypical myeloperoxidase-positive cells in the fetal 7 
vessels of the placenta and the umbilical cord suggested acute myeloid leukemia of the 8 
fetus.  It is known that fetus and neonate are liable to produce leukemoid reaction in 9 
response to congenital infection or eryhtroblastosis fetalis [3].  Although the placental 10 
pathology could also be explained by the leukemoid reaction, exclusion of congenital 11 
infection and eryhtroblastosis fetalis by maternal blood tests convinced us of the 12 
diagnosis of fetal leukemia. 13 
  The FTA became abnormally large after 29+6 weeks’ gestation, suggesting the 14 
development of fetal hepatosplenomegaly.  Abrupt elevation of UmA-PI can be 15 
explained by occlusion of the placental and the umbilical vessels by leukemic cells, as 16 
revealed by microscopic examination.  Polyhydramnios could be caused by increase of 17 
exudates from the infiltrated placental villi.  Subsequent decline of MCA-PI indicated 18 
that the blood flow redistribution towards the fetal brain took place as a compensating 19 
mechanism.  Since no cardiac anomaly was detected by fetal echocardiography and 20 
Doppler waveforms of inferior vena cava and ductus venosus were normal immediately 21 
prior to fetal death, the pleural effusion was considered to be due to pleural infiltration 22 
by leukemic cells rather than acute cardiac failure.  Loss of variability in FHR tracing 23 
followed by dip-like deceleration concurrent with uterine contraction and prolonged 24 
bradycardia might reflect fetal hypoxia caused by impaired oxygen supply to the fetus 25 
via the occluded umbilical vein.  Finally, fetal metabolic acidosis resulting from 26 
progressive hypoxia is considered to be a cause of sudden cardiac arrest.  Therefore, 27 
acute circulatory failure due to placental vessel occlusion by leukemic cells is likely to 28 
be a primary cause of the sudden fetal demise. 29 
  Hepatosplenomegaly and hydrops fetalis are two characteristic prenatal features of a 30 
leukemic fetus [4-6] [7-9].  Since extramedullary hematopoiesis physiologically occurs 31 
in liver and spleen during intrauterine period, fetuses easily develop 32 
hepatosplenomegaly in response to various hematological disorders including leukemia.  33 
 7 
Hepatosplenomegaly is often revealed as abnormally enlarged FTA.  In clinical 1 
practice, elevation of UmA-PI is most often seen in chronic uteroplacental insufficiency 2 
that is usually associated with restricted FTA growth.  Thus, elevation of UmA-PI with 3 
paradoxically enlarged FTA, as seen in the present case, may be an early sign of fetal 4 
leukemia.  5 
  Hydrops fetalis is generally associated with poor prognosis [10].  Two distinct 6 
mechanisms could be considered for hydrops development caused by fetal leukemia.  7 
The first is leukemic cell involvement of multiple fetal organs and placenta that yields 8 
excessive fluid accumulation in the fetal body and polyhydramnios.  In this case, 9 
multiple organ failure due to leukemic dissemination and/or acute circulatory failure 10 
due to placental vessel occlusion may lead to sudden fetal demise [9].  The second is 11 
chronic circulatory insufficiency due to hyperviscosity attributable to leukocytosis, 12 
which is often accompanied by oligohydramnios.   Hydrops fetalis in the second 13 
situation often takes a slower course than that in the first situation [7, 8]. 14 
  Prenatal diagnosis of congenital leukemia requires cordocentesis.  According to our 15 
PubMed search, prenatal diagnoses have been reported in only 10 cases [4, 5, 7, 8, 11, 16 
12].  Interestingly, all of these cases were associated with trisomy 21 (Down 17 
syndrome).  This suggests that leukemic fetuses associated with Down syndrome are 18 
likely to have a milder prenatal course than those without Down syndrome, thus giving 19 
a time for cordocentesis.  Supporting this, neonatal leukemia associated with Down 20 
syndrome has a natural tendency to undergo spontaneous remissions and reported 21 
mortality rate is much lower than that without Down syndrome (30% vs. 80%) [13, 14].  22 
  Leukemic fetuses, especially those without association of Down syndrome, usually 23 
require postnatal chemotherapy.  Although several reports described successful 24 
chemotherapy against leukemia during the early neonatal period [15-18], these neonates 25 
were in relatively stable conditions before initiating the chemotherapy.  Since most of 26 
the leukemic fetuses are likely to be already deteriorated in utero, the rescue might be 27 
difficult even if the prenatal diagnosis was established and the delivery was expedited 28 
before the fetal demise.  Recently, accumulating experiences of chemotherapy against 29 
pregnant women complicated with malignancies suggest that in-utero exposure to at 30 
least some of chemotherapeutic agents in the second and third trimester is relatively safe 31 
in terms of fetal malformation as well as both short- and long-term neonatal outcome 32 
[19-21].  Therefore, intrauterine chemotherapy might be an option to rescue prenatally 33 
 8 
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Figure legends 1 
 2 
Figure 1.  Sequential changes of pulsatility indices of umbilical artery (UmA-PI) (A) 3 
and middle cerebral artery (MCA-PI) (B) and ultrasonographic findings 12 hours prior 4 
to fetal death (C and D) 5 
(A, B)  Arrows indicate the time of fetal death.  Note acute elevation of UmA-PI and 6 
decline of MCA-PI from 4 days before fetal death at 30+3 weeks’ gestation.  (C) 7 
Amniotic fluid depth of 109.3mm indicates polyhydramnios.  (D) Echo-free space 8 
around fetal lung (arrowheads) represents pleural effusion. * indicates fetal heart. 9 
 10 
Figure 2.  Fetal cardiotocograms showing fetal heart rate (FHR) tracing in the upper 11 
panels and uterine contractions in the lower panels.   12 
(A) FHR tracing 13 hours before fetal death shows decreased beat-to-beat variability.  13 
(B) FHR tracing 4 hours before fetal death shows small dip-like deceleration on every 14 
uterine contraction.  (C) FHR tracing immediately before fetal death shows mild 15 
bradycardia (100-110 beat per minute) with loss of variability followed by sudden 16 
disappearance of FHR.  Arrow indicates the time of fetal death. 17 
 18 
Figure 3.  Placenta with fetal vessels showing leukocytosis.  Scale bars indicate 100 19 
µm.  20 
(A) Hematoxylin and Eosin (H&E) staining.  (B) Magnified image of the boxed area 21 
shown in (A). Intravillous capillary vessels (arrows) are filled with small- to 22 
medium-sized immature-looking atypical cells.  (C) H&E staining.  Umbilical artery 23 
(arrowheads) contains an aggregate of the atypical cells.  (D) Myeloperoxidase 24 
immunohistochemistry. Cytoplasmic staining of the atypical cells indicates myeloid 25 
lineage of derivation.  (E) Ki-67 (MIB-1) immunohistochemistry showing high 26 
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